Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice

BACKGROUND: As the most ordinary metabolic disorder during pregnancy, gestational diabetes mellitus (GDM) has become a severe risk for the health of both pregnant female and fetus. Astragaloside IV (AS-IV) is the dominant active component in Astragalus membranaceus. It has been proved that AS-IV has...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ruixue, Zhang, Xuelei, Xing, Baoheng, Zhao, Jianyong, Zhang, Peipei, Shi, Dandan, Yang, Fengzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764134/
https://www.ncbi.nlm.nih.gov/pubmed/31558153
http://dx.doi.org/10.1186/s12958-019-0522-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764134/
https://www.ncbi.nlm.nih.gov/pubmed/31558153
http://dx.doi.org/10.1186/s12958-019-0522-7

Ejemplares similares